相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。L-Carnitine and Acylcarnitines: Mitochondrial Biomarkers for Precision Medicine
Marc R. McCann et al.
METABOLITES (2021)
Aberrations in Lipid Expression and Metabolism in Psoriasis
Julia Nowowiejska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions
Yan Hao et al.
FRONTIERS IN IMMUNOLOGY (2021)
Next-generation sequencing of the whole mitochondrial genome identifies novel and common variants in patients with psoriasis, type 2 diabetes mellitus and psoriasis with comorbid type 2 diabetes mellitus
Materah Salem Alwehaidah et al.
BIOMEDICAL REPORTS (2021)
Diabetes and Psoriasis: Different Sides of the Same Prism
Rachel Abramczyk et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2020)
Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn's Disease
Yunjia Lai et al.
MOLECULES (2019)
Mitochondrial dysfunction in affected skin and increased mitochondrial DNA in serum from patients with psoriasis
Anastasia Therianou et al.
EXPERIMENTAL DERMATOLOGY (2019)
AMPK: Sensing Glucose as well as Cellular Energy Status
Sheng-Cai Lin et al.
CELL METABOLISM (2018)
Bioactive Lipid Mediator Profiles in Human Psoriasis Skin and Blood
Alexander Sorokin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Identification of PTPN22, ST6GAL1 and JAZF1 as psoriasis risk genes demonstrates shared pathogenesis between psoriasis and diabetes
Honglei Wang et al.
EXPERIMENTAL DERMATOLOGY (2017)
Stearoyl-CoA desaturase-1 and adaptive stress signaling
Andreas Koeberle et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)
Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity
Andrea Chiricozzi et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2016)
An Overview of the Pathogenesis of Immune-mediated Skin Injury
Dimitry M. Danilenko
TOXICOLOGIC PATHOLOGY (2016)
Candidate gene polymorphisms and risk of psoriasis: A pilot study
Alejandra Villarreal-Martinez et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Oxidation Reduction is a Key Process for Successful Treatment of Psoriasis by Narrow-band UVB Phototherapy
Xiaolian Gu et al.
ACTA DERMATO-VENEREOLOGICA (2015)
Insulin Resistance and Skin Diseases
Maddalena Napolitano et al.
TheScientificWorldJOURNAL (2015)
Insulin Resistance and Skin Diseases
Maddalena Napolitano et al.
Scientific World Journal (2015)
LC-MS Metabolomics of Psoriasis Patients Reveals Disease Severity-Dependent Increases in Circulating Amino Acids That Are Ameliorated by Anti-TNF alpha Treatment
Muhammad Anas Kamleh et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Acylcarnitines activate proinflammatory signaling pathways
Jennifer M. Rutkowsky et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Mitochondrial target of thiazolidinediones
J. R. Colca et al.
DIABETES OBESITY & METABOLISM (2014)
Mitochondrial dysfunction: a neglected component of skin diseases
Rene G. Feichtinger et al.
EXPERIMENTAL DERMATOLOGY (2014)
Age at disease onset: a key factor for understanding psoriatic disease
Ruben Queiro et al.
RHEUMATOLOGY (2014)
Plasma and urine metabolic profiles are reflective of altered beta-oxidation in non-diabetic obese subjects and patients with type 2 diabetes mellitus
Jesus Zacarias Villarreal-Perez et al.
DIABETOLOGY & METABOLIC SYNDROME (2014)
Serum Levels of Acylcarnitines Are Altered in Prediabetic Conditions
Manuel Mai et al.
PLOS ONE (2013)
Obesity and Inflammation: Epidemiology, Risk Factors, and Markers of Inflammation
Heriberto Rodriguez-Hernandez et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2013)
Lysine post-translational modifications of collagen
Mitsuo Yamauchi et al.
LYSINE-BASED POST-TRANSLATIONAL MODIFICATION OF PROTEINS (2012)
The Definition of Insulin Resistance Using HOMA-IR for Americans of Mexican Descent Using Machine Learning
Hui-Qi Qu et al.
PLOS ONE (2011)
Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery
J. Mark Brown et al.
CURRENT OPINION IN LIPIDOLOGY (2010)
Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions
Batya B. Davidovici et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Increased Levels of Plasma Acylcarnitines in Obesity and Type 2 Diabetes and Identification of a Marker of Glucolipotoxicity
Stephanie J. Mihalik et al.
OBESITY (2010)
Role of Oxidative Stress in Various Stages of Psoriasis
Dipali P. Kadam et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2010)
Guidelines of care for the management of psoriasis and psoriatic arthritis - Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Role of stearoyl-CoA desaturase in human metabolic disease
Harini Sampath et al.
FUTURE LIPIDOLOGY (2008)
Prevalence of cardiovascular risk factors in patients with psoriasis
Andrea L. Neimann et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
A new therapeutic approach to treat psoriasis by inhibition of fatty acid oxidation by Etomoxir
F Caspary et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
The antipsoriatic drug anthralin accumulates in keratinocyte mitochondria, dissipates mitochondrial membrane potential, and induces apoptosis through a pathway dependent on respiratory competent mitochondria
A McGill et al.
FASEB JOURNAL (2005)
Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity
JM Ntambi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
分享论文
